Paul Adler Biography and Net Worth

CEO of CareDx


Paul Adler is the CEO of CareDx.

How do I contact Paul Adler?

The corporate mailing address for Adler and other CareDx executives is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. CareDx can also be reached via phone at (415) 287-2300 and via email at [email protected]. Learn More on Paul Adler's contact information.

Has Paul Adler been buying or selling shares of CareDx?

Paul Adler has not been actively trading shares of CareDx during the last ninety days. Learn More on Paul Adler's trading history.

Who are CareDx's active insiders?

CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Ankur Dhingra (CFO), Michael Goldberg (Director), William Hagstrom (Director), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director). Learn More on CareDx's active insiders.

Are insiders buying or selling shares of CareDx?

In the last twelve months, insiders at the sold shares 12 times. They sold a total of 47,266 shares worth more than $430,497.99. The most recent insider tranaction occured on October, 2nd when insider Reginald Seeto sold 2,818 shares worth more than $19,472.38. Insiders at CareDx own 4.2% of the company. Learn More about insider trades at CareDx.

Information on this page was last updated on 10/2/2023.

Paul Adler Insider Trading History at CareDx

See Full Table

Paul Adler Buying and Selling Activity at CareDx

This chart shows Paul Adler's buying and selling at CareDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CareDx Company Overview

CareDx logo
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $10.59
Low: $10.28
High: $11.10

50 Day Range

MA: $9.67
Low: $7.96
High: $12.08

2 Week Range

Now: $10.59
Low: $4.80
High: $12.93

Volume

696,817 shs

Average Volume

1,037,913 shs

Market Capitalization

$548.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42